Literature DB >> 28898899

Platelets as Modulators of Liver Diseases.

Ton Lisman1, James P Luyendyk2.   

Abstract

Platelets are key players in thrombosis and hemostasis. Alterations in platelet count and function are common in liver disease, and may contribute to bleeding or thrombotic complications in liver diseases and during liver surgery. In addition to their hemostatic function, platelets may modulate liver diseases by mechanisms that are incompletely understood. Here, we present clinical evidence for a role of platelets in the progression of chronic and acute liver diseases, including cirrhosis, acute liver failure, and hepatocellular carcinoma. We also present clinical evidence that platelets promote liver regeneration following partial liver resection. Subsequently, we summarize studies in experimental animal models that support these clinical observations, and also highlight studies that are in contrast with clinical observations. The combined results of clinical and experimental studies suggest that platelets may be a therapeutic target in the treatment of liver injury and repair, but the gaps in our understanding of mechanisms involved in platelet-mediated modulation of liver diseases call for caution in clinical application of these findings. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28898899      PMCID: PMC5823745          DOI: 10.1055/s-0037-1604091

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  139 in total

1.  Pitfalls in assessing platelet activation status in patients with liver disease.

Authors:  Ton Lisman; Robert J Porte
Journal:  Liver Int       Date:  2011-12-30       Impact factor: 5.828

2.  Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study.

Authors:  James F Trotter; Brenda W Gillespie; Norah A Terrault; Michael M Abecassis; Robert M Merion; Robert S Brown; Kim M Olthoff; Paul H Hayashi; Carl L Berg; Robert A Fisher; James E Everhart
Journal:  Liver Transpl       Date:  2011-04       Impact factor: 5.799

3.  Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.

Authors:  Ton Lisman; Robert J Porte
Journal:  Blood       Date:  2010-04-16       Impact factor: 22.113

4.  CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.

Authors:  Mirko Moreno Zaldivar; Katrin Pauels; Philipp von Hundelshausen; Marie-Luise Berres; Petra Schmitz; Jörg Bornemann; M Anna Kowalska; Nikolaus Gassler; Konrad L Streetz; Ralf Weiskirchen; Christian Trautwein; Christian Weber; Hermann E Wasmuth
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

Review 5.  Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient.

Authors:  Freeha Arshad; Ton Lisman; Robert J Porte
Journal:  Liver Int       Date:  2013-03-15       Impact factor: 5.828

Review 6.  Liver sinusoidal endothelial cells: Physiology and role in liver diseases.

Authors:  Johanne Poisson; Sara Lemoinne; Chantal Boulanger; François Durand; Richard Moreau; Dominique Valla; Pierre-Emmanuel Rautou
Journal:  J Hepatol       Date:  2016-07-14       Impact factor: 25.083

7.  The profile of platelet α-granule released molecules affects postoperative liver regeneration.

Authors:  Patrick Starlinger; Stefanie Haegele; Florian Offensperger; Lukas Oehlberger; David Pereyra; Julia B Kral; Waltraud C Schrottmaier; Sigrun Badrnya; Thomas Reiberger; Arnulf Ferlitsch; Judith Stift; Florian Luf; Christine Brostjan; Thomas Gruenberger; Alice Assinger
Journal:  Hepatology       Date:  2015-12-28       Impact factor: 17.425

8.  Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model.

Authors:  Mohammad Akbar Hossain; Dong Hwan Kim; Jung Yoon Jang; Yong Jung Kang; Jeong-Hyun Yoon; Jeon-Ok Moon; Hae Young Chung; Gi-Young Kim; Yung Hyun Choi; Bryan L Copple; Nam Deuk Kim
Journal:  Int J Oncol       Date:  2011-12-15       Impact factor: 5.650

Review 9.  The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Qing Pang; Kai Qu; Jing-Yao Zhang; Si-Dong Song; Su-Shun Liu; Ming-Hui Tai; Hao-Chen Liu; Chang Liu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  Immediate Postoperative Low Platelet Counts After Living Donor Liver Transplantation Predict Early Allograft Dysfunction.

Authors:  Lei Li; Haiqing Wang; Jian Yang; Li Jiang; Jiayin Yang; Wentao Wang; Lvnan Yan; Tianfu Wen; Bo Li; Mingqing Xu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more
  14 in total

1.  Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans.

Authors:  Dafna Groeneveld; David Pereyra; Zwanida Veldhuis; Jelle Adelmeijer; Petra Ottens; Anna K Kopec; Patrick Starlinger; Ton Lisman; James P Luyendyk
Journal:  Blood       Date:  2019-01-17       Impact factor: 22.113

Review 2.  Role of liver sinusoidal endothelial cells in liver diseases.

Authors:  Jordi Gracia-Sancho; Esther Caparrós; Anabel Fernández-Iglesias; Rubén Francés
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-15       Impact factor: 46.802

3.  Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Suguru Ikeda; Takaaki Sugihara; Yoshiki Hoshino; Yukako Matsuki; Takakazu Nagahara; Jun-Ichi Okano; Sonoko Kitao; Youhei Fujioka; Kazuhiro Yamamoto; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2020-08-07       Impact factor: 1.641

Review 4.  Role of the blood coagulation cascade in hepatic fibrosis.

Authors:  Asmita Pant; Anna K Kopec; James P Luyendyk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-03       Impact factor: 4.052

5.  Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice.

Authors:  Dafna Groeneveld; Holly Cline-Fedewa; Kevin S Baker; Kurt J Williams; Robert A Roth; Karen Mittermeier; Ton Lisman; Joseph S Palumbo; James P Luyendyk
Journal:  J Hepatol       Date:  2019-10-10       Impact factor: 30.083

Review 6.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

Review 7.  Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?

Authors:  Marie-Astrid van Dievoet; Stéphane Eeckhoudt; Xavier Stephenne
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

8.  Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy.

Authors:  Friedrich Reusswig; Nastaran Fazel Modares; Marius Brechtenkamp; Leonard Wienands; Irena Krüger; Kristina Behnke; Melissa M Lee-Sundlov; Diran Herebian; Jürgen Scheller; Karin M Hoffmeister; Dieter Häussinger; Margitta Elvers
Journal:  Hepatology       Date:  2021-06-04       Impact factor: 17.298

9.  Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis.

Authors:  Adil Bhat; Sukanta Das; Gaurav Yadav; Sudrishti Chaudhary; Ashish Vyas; Mojahidul Islam; Abhishak C Gupta; Meenu Bajpai; Rakhi Maiwall; Jaswinder Singh Maras; Shiv K Sarin
Journal:  Hepatol Commun       Date:  2019-11-23

10.  Genetic variants associated with platelet count are predictive of human disease and physiological markers.

Authors:  Evgenia Mikaelsdottir; Gudmar Thorleifsson; Lilja Stefansdottir; Gisli Halldorsson; Jon K Sigurdsson; Sigrun H Lund; Vinicius Tragante; Pall Melsted; Solvi Rognvaldsson; Kristjan Norland; Anna Helgadottir; Magnus K Magnusson; Gunnar B Ragnarsson; Sigurdur Y Kristinsson; Sigrun Reykdal; Brynjar Vidarsson; Ingibjorg J Gudmundsdottir; Isleifur Olafsson; Pall T Onundarson; Olof Sigurdardottir; Emil L Sigurdsson; Gerdur Grondal; Arni J Geirsson; Gudmundur Geirsson; Julius Gudmundsson; Hilma Holm; Saedis Saevarsdottir; Ingileif Jonsdottir; Gudmundur Thorgeirsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Commun Biol       Date:  2021-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.